Jose E. Manautou
Professor & Department Head/Pharmaceutical Science
Storrs Mansfield
Are you Jose E. Manautou?
How to update your information.
Scholarly Contributions
186 Scholarly Contributions
Nrf2 Influences the Regulation of PPAR-Dependent Genes in Mouse Liver
2017
Research Type: Poster/Presentation
Novel Genetic Determinants of Acetaminophen Toxicity and the Potential for Validation as Biomarkers
2017
Research Type: Poster/Presentation
Non-Alcoholic Fatty Liver Disease and Drug Transporters: What is the Connection?
2021
Research Type: Poster/Presentation
Non-Alcoholic Fatty Liver Disease Phenotype in Regenerating Liver pf Multidrug-Resistance Associated Protein-4 (Mpr4) Deficient Mice
2019
Research Type: Poster/Presentation
New Approaches to Identify Adaptive/Adverse Responses: Liver As a Model System
2014
Research Type: Poster/Presentation
Nedosiran, a Candidate siRNA Drug for the Treatment of Primary Hyperoxaluria: Design, Development, and Clinical Studies
2022
Research Type: Other Scholarly Work
Multivalent Lactobionic Acid and N-Acetylgalactosamine-Conjugated Peptide Nucleic Acids for Efficient In Vivo Targeting of Hepatocytes
2023
Research Type: Journal Article
Multiplicity of 5'-end of human hepatic multidrug resistance-associated protein 4 transcripts
2012
Research Type: Poster/Presentation
Multidrug resistance-associated protein 4 (Mrp4) is a novel genetic factor in the pathogenesis of obesity and diabetes.
2021
Research Type: Journal Article
Multidrug resistance-associated protein 4 (Mrp4) expression and its relationship to obesity and diabetes
2020
Research Type: Poster/Presentation
Multidrug resistance protein 4 (Mrp4), a drug transporter is a novel genetic determinant for adipogenesis
2018
Research Type: Poster/Presentation
Multidrug resistance protein 4 (Mrp4) regulates nutrient and energy metabolism by altering the adipose tissue physiology
2019
Research Type: Poster/Presentation
Multidrug Resistance-Associated Protein 4 Versatility as an Eflflux Drug Transporter Now Expands to Non-Alcoholic Fatty Liver Disease and Adipogenesis
2018
Research Type: Poster/Presentation
Multidrug Resistance-Associated Protein 4 (Mrp4) Is a Novel Genetic Factor in the Pathogenesis of Obesity and Diabetes
2020
Research Type: Poster/Presentation
Multidrug Resistance-Associated Protein 4 (MRP4) Plays a Crucial Role in the Pathogenesis of Fatty Liver Disease
2019
Research Type: Poster/Presentation
Multidrug Resistance-Associated Protein 3 Plays an Important Role in Protection against Acute Toxicity of Diclofenac.
2015
Research Type: Journal Article
Multidrug Resistance Protein-4 (Mrp4): A New Member in the Constellation of Factors Contributing to Non-alcoholic Fatty Liver Disease and Metabolic Syndrome
2022
Research Type: Poster/Presentation